Releases - Biotage

View:
 

Found press releases

 

Biotage AB launches share buy-back

4/26/2013 7:00 AM EST
The board of directors of Biotage AB (publ) has resolved to start a share buy-back program in accordance with the Annual General Meeting’s resolution to authorize the board to decide on the acquisition and sale of the company’s own shares.
At the Annual General Meeting held on 25 April 2013, the board was authorized to decide on the acquisition and sale of the company’s own shares up and until the forthcoming...

Resolutions at the Annual General Meeting in Biotage AB on April 25, 2013

4/25/2013 11:30 AM EST
At the Annual General Meeting held in Biotage AB (Reg. No. 556539-3138) on April 25, 2013, the following resolutions were passed, among others.

Appropriation of the company’s result

The General Meeting resolved a dividend of SEK 0.50 per share, which in aggregate is a dividend in the amount of no higher than SEK 34,930,665.

Record date for dividend was resolved to be Tuesday, 30 April 2013.

Board of Directors....

Interim report January - March 2013

4/25/2013 9:00 AM EST
First quarter January – March 2013

· Group net sales in the first quarter 2013 amounted to 103.2 MSEK (119.6) which is a 13.7 percent decrease. At comparable exchange rates the sales decreased by 6.9 percent compared to the corresponding quarter 2012.
· Operating profit for the quarter amounted to 6.1 MSEK (8.6).
· The result after tax for the period amounted to 3.1 MSEK (7.9).
· Earnings per share amounted to...

Biotage AB (publ) publishes its 2012 Annual Report, Corporate Governance Report ...

4/4/2013 3:00 AM EST
The following financial goals for the three-year period 2013 – 2015, as an average for the period, have been determined:

· Organic growth 8 %
Biotage’s goal is to achieve an average organic growth of 8 per cent. This is an ambitious target taking into account that many of the markets where Biotage are operating currently do show lower growth numbers. To achieve this goal, Biotage needs to succeed in addressing a...

NOTICE OF ANNUAL GENERAL MEETING IN BIOTAGE AB (publ)

3/25/2013 3:00 AM EST
The shareholders in Biotage AB are hereby summoned to the annual general meeting (the “Meeting”), to be held on Thursday, April 25, 2013, at 4.00 p.m., at the head office of Biotage AB, Vimpelgatan 5 in Uppsala, Sweden.

Notice etc.
Shareholders who wish to participate in the Meeting must
a) be recorded as a shareholder in the share register maintained by Euroclear Sweden AB on Friday, April 19, 2013, and
b) notify...

Food contact notification to FDA

3/4/2013 4:00 AM EST
Biotage AB (publ) through its subsidiary MIP Technologies AB submits Food Contact Notification (FCN) to U.S. Food and Drug Administration (FDA)
Biotage acquired MIP Technologies in 2010 to gain access to world class development capabilities of custom designed molecular imprinted and other novel polymers. Following the acquisition Biotage has invested in the industrialization of MIP Technologies’ business...

Year-end report for 2012

2/12/2013 2:00 AM EST
Fourth quarter October - December 2012     

· Group net sales in the fourth quarter 2012 amounted to 113.9 MSEK (116.0), a 1.8 percent decrease. At comparable exchange rates the sales increased by 1.5 percent compared to the corresponding quarter 2011.
· Operating profit for the quarter amounted to 13.5 MSEK (9.8).
· The result after tax amounted to 13.6 MSEK (17.2).
· Earnings per share amounted to 0.19 SEK...

Biotage success in re-examination proceedings

1/16/2013 2:00 AM EST
– US Patent and Trademark Office’s Patent Trial and Appeal Board have affirmed the Examiner’s decisions to reject all claims in US patents 7,138,061, 7,381,327 and 7,410,571.
A lawsuit was filed against Biotage by Scientific Plastic Products, Inc. (“SPP”) concerning alleged infringement of the US patents no 7,138,061, 7,381,327 and 7,410,571. Biotage then filed applications to the US Patent and Trademark Office...

Interim report for the period January - September 2012

10/26/2012 2:00 AM EST
Third quarter July - September 2012                                                                                                           

· Group net sales in the third quarter 2012 increased by 1 percent to 107.1 MSEK (106.6). At comparable exchange rates the sales were at the same level as the corresponding quarter 2011.
· Operating profit in the quarter amounted to 8.9 MSEK (10.9).
· The result after tax...

Biotage AB Nomination Committee

10/16/2012 2:00 AM EST
A Nomination Committee consisting of shareholder representatives and the Chairman of the Board of Directors has been formed for Biotage AB. The Nomination Committee shall, before the Annual General Meeting 2013, prepare proposals for the election of Chairman and other members of the Board of Directors, the election of Chairman of the Annual General Meeting, election of Auditors, the determination of fees and matters...

Biotage

RSS

Biotage accelerates the drug discovery and development process and increases the knowledge of the importance of the genetic make-up by providing complete solutions for medicinal chemistry research and applied genetic ana...

View more


  CONTACT